Poor prognosis of heart transplant patients with end-stage renal failure

Nephrology Dialysis Transplantation

Volumn 22, Issue 5, 2007, Pages 1383-1389

  Villar, Emmanuel ^a   Boissonnat, Pascale ^a   Sebbag, Laurent ^a   Hendawy, Achraf ^a   Cahen, Rémi ^a   Trolliet, Pierre ^a   Labeeuw, Michel ^a   Ecochard, René ^a   Pouteil Noble, Claire ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Dialysis; End stage renal failure; Heart transplant; Renal transplant; Survival

Indexed keywords

CALCINEURIN INHIBITOR;

ADULT; ARTICLE; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DIALYSIS; FEMALE; FOLLOW UP; HAZARD RATIO; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; NEPHROTOXICITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SUDDEN DEATH; SURVIVAL RATE;

AGED; CAUSE OF DEATH; FEMALE; HEART TRANSPLANTATION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 34447550510     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl811     Document Type: Article

References (34)

1. Bloom RD, Doyle AM. Kidney disease after heart and lung transplantation. Am J Transplant 2006; 6: 671-679
2. Ojo AO, Held PJ, Port FK et al. Chronic renal failure after transplantation of a nonrenal organ. N Eng J Med 2003; 349: 931-940
3. Wilkinson AH, Cohen DJ. Renal failure in the recipients of nonrenal solid organ transplants. J Am Soc Nephrol 1999; 10: 1136-1144
4. Goldstein DJ, Zuech N, Sehgal V, Weinberg AD, Drusin R, Cohen D. Cyclosporine-associated end-stage renal nephropathy after cardiac transplantation. Transplantation 1997; 63: 664-668
5. Horneberger J, Best J, Geppert J, McClellan M. Risks and costs of end-stage renal disease after heart transplantation. Transplantation 1998; 66: 1763-1770
6. Rubel JR, Milford EL, McKay DB, Jarcho JA. Renal insufficiency and end-stage renal disease in the heart transplant population. J Heart Lung Transplant 2004; 23: 289-300
7. Esposito C, Semeraro L, Belloti N et al. Risk factors for chronic renal dysfunction in cardiac allograft recipients. Nephron 2000; 84: 21-28
8. Sénéchal M, Dorent R, Tézénas du Montcel S et al. End-stage renal failure and cardiac mortality after heart transplantation. Clin Transplant 2004; 18: 1-6
9. Hendawy A, Pouteil-Noble C, Villar E, Boissonat P, Sebbag L. Chronic renal failure and end-stage renal disease are associated with a high rate of mortality after heart transplantation. Transplant Proc 2005; 37: 1352-1354
10. Garrido IP, Crespo-Leiro MG, Paniagua MJ et al. Independent predictors of renal dysfunction after heart transplantation in patients with normal pretransplant renal function. J Heart Lung Transplant 2005; 24: 1226-1230
11. Abraham KA, McGorrian C, O'Kelly P et al. The effect of pre-existing ischaemic heart disease on renal dysfunction in cardiac transplant recipients. Am J Transplant 2002; 2: 355-359
12. Herlitz H, Lindelöw B. Renal failure following cardiac transplantation. Nephrol Dial Transplant 2000; 15: 311-314
13. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine-associated chronic nephropathy. N Eng J Med 1984; 311: 6991-705
14. Myers BD, Newton L. Cyclosporine-induced chronic nephropathy: An obliterative microvascular renal injury. J Am Soc Nephrol 1991; 2: S45-S52
15. Frimat L, Villemot JP, Cormier L et al. Treatment of end-stage renal failure after heart transplantation. Nephrol Dial Transplant 1998; 13: 2905-2908
16. Jayasena SD, Riaz A, Lewis CM, Neil GH, Thompson FD, Woolson RG. Outcome in patient with end-stage renal disease following heart or heart-lung transplantation receiving peritoneal dialysis. Nephrol Dial Transplant 2001; 16: 1681-1685
17. Bernardini J, Piraino B, Kormos RL. Patient survival with renal replacement therapy in heart transplantation patients. ASAIO J 1998; 44: 548
18. Schoenfeld DA, Richter DJ. Nomograms for calculating the numbers of patients needed for a clinical trial with survival as an endpoint. Biometrics 1982; 38: 163-170
19. Couchoud C, Stengel B, Landais P et al. The renal epidemiology and information network (REIN): A new registry for end-stage renal disease. Nephrol Dial Transplant 2006; 21: 411-418
20. Cox DR. Regression models and life tables (with discussion). J R Stat Soc 1972; 34: 197-220
21. Therneau TM, Grambsch PM. Testing proportional hazards. In: Rochester MN, ed. Modeling survival data: Extending the Cox model. Mayo foundation and Patricia Grambsch, Springer, USA: 2000; 127-152
22. Frimat L, Durand PY, Loos-Ayav C et al. Impact of first dialysis modality on outcome of patients contraindicated for kidney transplant. Perit Dial Int 2006; 26: 231-239
23. Berthoux F. European Best Practice Guidelines. Section I: Evaluation, selection and preparation of the potential transplant recipient. Nephrol Dial Transplant 2000; 15 [Suppl 7]: 3-38
24. Couchoud C, Pozet N, Labeeuw M, Pouteil-Noble C. Screening early renal failure: Cut-off values for serum creatinine as an indicator of renal impairment. Kidney Int 1999; 55: 1878-1884
25. El Nahas AM, Bello A. Chronic kidney disease: The global challenge. Lancet 2005; 365: 331-340
26. English RF, Pophal SA, Bacanu SA et al. Long-term comparison of tacrolimus and cyclosporine induced nephrotoxicity in pediatric heart-transplant recipients. Am J Transplant 2002; 2: 769-773
27. Israni A, Brozena S, Pankewycz O, Grossman R, Bloom R. Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients. Am J Kidney Dis 2002; 39: E16
28. Angermann CE, Störk S, Costard-Jäckle A et al. Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients - The IMPROVED multi-centre study. Eur Heart J 2004; 25: 1626-1634
29. Groetzner J, Meiser B, Landwehr P et al. Mycophenolate mofetil and sirotimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant rejection with chronic renal failure. Transplantation 2004; 77: 568-574
30. Besetti R, Theodoropoulos TAD, Burdmann EA, Filho MA, Cordeiro JA, Villafanha D. Switch from calcineurin inhibitors to sirolimus induced renal recovery in heart transplant recipients in the mid-term follow-up. Transplantation 2006; 81: 692-696
31. Meiser B, Reichart B, Adamidis I, Uberfuhr P, Kaczmarek I. First experience with de novo calcineurin-inhibitor-free immunosuppression following cardiac transplantation. Am J Transplant 2005; 5: 827-831
32. Kuo PC, Luikart H. Busse-Henry S et al. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients. Clin Transplant 1995; 9: 92-97
33. Shwaiger JP, Lamina C, Neyer U et al. Carotid plaques and their predictive value for cardiovascular disease and all-cause mortality in hemodialysis patients considering renal transplantation: A decade follow-up. Am J Kidney Dis 2006; 47: 888-897
34. Wolfe R, Ashby W, Milford E et al. Comparison of mortality in all patients on dialysis, patient on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Eng J Med 1999; 341: 1725-1730